NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins.

Source:http://linkedlifedata.com/resource/pubmed/id/18992939

Download in:

View as

General Info

PMID
18992939